/Zoetis%20Inc%20magnified-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $66.9 billion, Zoetis operates as the world's largest producer of medicines and vaccines for pets and livestock, with operations spanning over 100 countries in North America, Europe, and internationally.
The healthcare giant is set to announce its first-quarter results before the market opens on Tuesday, May 6. Ahead of the event, analysts expect ZTS to report an adjusted profit of $1.40 per share, up a modest 1.5% from $1.38 per share reported in the year-ago quarter. On a more positive note, ZTS has surpassed the Street’s bottom-line estimates in each of the past four quarters.